Literature DB >> 8484141

[Management of unstable forearm shaft fractures in children].

G Bauer1, O Gonschorek.   

Abstract

Complete dislocation fractures of the forearm are rare in children. Operative treatment is indicated if it is an open fracture and if neurovascular injury is present. There is no accepted standard treatment--operative or nonoperative--for fractures that cannot be accurately reduced and stabilized. In the last 10 years we have operated on 37 fractures of the forearm in children. In 22 cases the indication for operative treatment was that the fractures could either not be reduced or could not be stabilized. Our results show that most fractures were not recognized as unstable (17 out of 22 cases), and therefore several reduction maneuvers (2 to 4 times) were performed before definitive stabilization was obtained via an operation. It is therefore mandatory that unstable fractures of both bones or of one bone be operated on whereas semistable fractures (one bone completely fractured) should be reduced under general anesthesia and operative standby. For the surgical treatment of unstable forearm fractures we recommend intramedullary fixation by dynamic nailing or plate osteosynthesis in younger patients (5-10 years) and open reduction and plate osteosynthesis in older patients and in open fractures or fractures with primary neurovascular impairment.

Entities:  

Mesh:

Year:  1993        PMID: 8484141

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  2 in total

1.  [The multi-point contact (MPC) osteosynthesis plate. 2: Initial clinical results of therapy of forearm fracture with MPC plates].

Authors:  J F Hönig; H Burchardt; M Wüstner; P Stankovic; A Schmid; K M Stürmer
Journal:  Unfallchirurgie       Date:  1997-12

2.  [New aspects in the treatment of complete and isolated diaphyseal fracture of the forearm in childhood].

Authors:  A M Würfel; A Voigt; F Linke; S Hofmann von Kap-herr
Journal:  Unfallchirurgie       Date:  1995-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.